Skip to main content
BI · NSE
Market closedNSE | BSE
Loading live market indices
BI
NSE · Equity shares · Containers & Packaging

Bilcare BI

NSE:INR 63Recorded price
BSE:INR 60.5Recorded price
Not available · Not available
Advanced chart
Data quality and coveragePrice, company fundamentals and optional research feeds are tracked separately.
Headline priceStale · last-known data
Company fundamentalsStale · last-known data
Research sections8 of 9 availableMissing source values remain unavailable, never zero-filled.
Snapshot

Price and key statistics

Reported and computed values remain separate; missing values are not converted to zero.

Previous closeData unavailable
Day rangeINR 58.6 — INR 60.5
52-week rangeINR 50 — INR 116
VolumeNot available
Market cap142.51
P/E83.15
Fundamental highlightsReported values unless marked as computed
Revenue (INR Cr)733.54
Net Income (INR Cr)1.72
Rev Growth (5 Year %)3.33
P/E Ratio83.15
Book Value80.3
EPS1.78
Price/BV0.78Computed
AI and Advanced

AI analysis and Advanced tools for BI

Analysis, reports, chat and Advanced access use the same Rusaka Markets account. The backend remains authoritative for roles, subscriptions, credits and permissions.

AI analysisReview the complete evidence-led AI research workflow.Generate reportCreate a versioned report with entitlement and credit checks.Open AI ChatContinue a grounded conversation with the instrument in context.Advanced modulesOpen role- and entitlement-controlled portfolio and trading tools.
Validated OHLC

Interactive price chart

Crosshair, OHLCV tooltip, indicators, volume, zoom and pan use the same candle API as the advanced workspace.

Interactive price chartInteractive chart loads when this section is visible.
Auditable calculations

Daily technical summary

Calculated from validated daily candles. Descriptive research only.

Calculating technicals…
Intelligence: activity, structure and reported deals

Indicators describe price behaviour and volatility; they are not a BUY, NEUTRAL or SELL recommendation.

Company derivatives · NSE

BI futures & options

Expiry structure, futures, option chains and contract research.

Snapshot · timestamp unavailable
No observations

No matching contracts have verified observations for this filter.

DIRECTION · ACTIVITY · DISCLOSURES

BI Intelligence

Stored price, volume, causal structure and reported deals for this stock.

Market map
Checking research access…

Volume and pressure are activity estimates, not net money inflow. Futures and options retain their separate observations above.

Company reporting

Financial statements

IND AS · INR crore

Metric202620252024
Total Liabilities Shareholders' Equity842.83924.1977.21
Other Liabilities Total13.1317.163.63
Long Term Debt449.72451.47544.47
Common Stock Total23.5523.5523.55
Other Current Assets Total77.1677.188.13
Total Assets842.83924.1977.21
Current Portof LT Debt/Capital Leases160.42218.74210.64
Cash5.5115.0136.42
Total Equity196.73214.22210.94
Long Term Investments25.5797.7595.32
Retained Earnings(Accumulated Deficit)173.18190.67187.39
Total Common Shares Outstanding2.352.352.35
Tangible Book Valueper Share Common Eq80.386.2184.3
Total Liabilities646.1709.88766.27
Total Debt620.44689.1756.05
Short Term Investments46.9814.4216.15
Cashand Short Term Investments52.4929.4352.57
Total Receivables Net108.83119.36164.24
Deferred Income Tax3.387.322.5
Accounts Receivable-Trade Net108.04118.89149.82
Property/Plant/Equipment Total-Net433.74448.98436.54
Minority Interest-122.59-124.59-155.32
Total Current Liabilities292.16339.65350.05
Total Inventory114.84117.12106.25
Accounts Payable93.7583.6896.58
Other Currentliabilities Total37.9937.2342.83
Total Long Term Debt460.02470.36545.41
Intangibles Net7.6611.2312.46
Other Long Term Assets Total14.8913.6413.07
Note Receivable-Long Term7.659.498.63
Total Current Assets353.32343.01411.19
Capital Lease Obligations10.318.890.94
Fundamentals

Valuation and ratios

Growth

Debt 5Yr CAGR %-1.74

Margins

Operating Margin 12m0.96

Operating Margin 5y Avg8

Net Profit Margin 12m-4.24

Net Profit Margin 5y-1.42

Yield

Dividend Yield %0

Valuation

Price to Sale Ratio0.19

Risk and consensus

Source-qualified signals

Risk metrics

Overall RiskBalanced risk

Board Risk44.9

Analyst consensus

Analyst consensus unavailable.
Provider consensus uses a 1 (Strong Buy) to 5 (Strong Sell) score. The payload does not include price targets, so none are inferred from 52-week prices or recommendation percentages.
Industry context

Peer comparison

Only peers present in the company profile payload are displayed.

CompanyPriceMarket capP/EResearch
EPLINR 234.057,485.418.66—
AGI GreenpacINR 674.554,361.6112.66—
Xpro IndiaINR 1,357.33,182.45166.68—
UflexINR 5053,660.269.47—
TCPL PackagingINR 3,339.22,987.8326.65—
Shareholding

Ownership

Promoter
30.01%
FII
0.04%
Other
69.95%
Corporate actions

Events

  1. annual General MeetingPOM
  2. board MeetingsAudited Results
  3. board MeetingsQuarterly Results
  4. board MeetingsQuarterly Results
  5. annual General Meeting(Revised)
  6. board MeetingsQuarterly Results
  7. board MeetingsAudited Results
  8. board MeetingsQuarterly Results
  9. board MeetingsQuarterly Results
  10. annual General MeetingA.G.M.
  11. board MeetingsQuarterly Results
  12. board MeetingsAudited Results
  13. board MeetingsQuarterly Results
  14. board MeetingsQuarterly Results
  15. annual General MeetingA.G.M.
  16. board MeetingsQuarterly Results
  17. board MeetingsAudited Results
  18. annual General MeetingEGM
  19. board MeetingsInter-alia, a) To transfer, assign, restructure or convey the whole or substantially the whole of the business undertaking by way of slump sale as a "going concern" or otherwise.
  20. board MeetingsQuarterly Results
Rusaka Markets Community

Discussion and sentiment for Bilcare

Posts are linked to the canonical company record. Community BUY, NEUTRAL and SELL opinions are user-generated, moderated and separate from analyst consensus and Rusaka Markets AI.

Rusaka Markets Community

Community discussion loads as you approach this section.

Company profile

Business information

What the company does

Bilcare Limited is an India-based company. The Company is engaged in the business of Pharmaceutical Packaging, Global Clinical Services, and Research and Development (R&D) services. It has a single operating segment, namely Pharma Packaging Research Solutions. The Company offers a range of Pharma Packaging solutions, namely Blister Films, Blister Foils, Lidding Foils, Child-resistant (CR) Foils, and Laminations. Its R&D services include Formulation stability studies, Blister / Foil design & development, Pharma brand innovation, Analytical research & market study, and Packaging trials & audit. The Company has five subsidiaries, namely Bilcare GCS Limited, Bilcare Inc., Bilcare GCS Inc., Bilcare GCS Ireland Limited, Bilcare Pharma Solutions Limited, and Caprihans India Limited. Its annual manufacturing capacity is approximately 50000 tons. The Company has manufacturing facilities in Nashik, Pune, and Thane.

Company facts

Industry
Containers & Packaging
Sector
Containers & Packaging
NSE Code
BI
BSE Code
526853
Questions

Stock FAQ

What is the symbol and ISIN of Bilcare?

Bilcare has the symbol BI and ISIN - INE986A01012.

What is the latest recorded price of Bilcare?

The latest available recorded price of Bilcare is INR 63.00 as of 2026-07-22T06:37:12.166Z. This is a source-stamped snapshot, not a live quote.

What are the year high and year low of Bilcare?

Year high: INR 116.00. Year low: INR 50.00.

What is the market capitalization of Bilcare?

Market capitalization: INR 142.51 crore.

What is the P/E ratio of Bilcare?

P/E ratio: 83.15.

What is the dividend yield of Bilcare?

Dividend yield: 0.00%.

How is the financial performance of Bilcare based on revenue, net income, and EPS?

Revenue: INR 733.54 crore. Net income: INR 1.72 crore. EPS: INR 0.30.

What is the book value of Bilcare?

Book value: INR 80.30.

What are the price-to-book and price-to-sales ratios of Bilcare?

Price-to-book ratio: 0.78. Price-to-sales ratio: 0.19.

Corporate-action adjustment is provider-defined. Rusaka Markets research and computed indicators are not investment advice.